CTKB Q1 2025 Earnings — Cytek Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CTKBCytek Biosciences, Inc.

$553M

Q1 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$41M-7.6% YoY

Gross Profit

$20M48.6% margin

Operating Income

-$15M-36.1% margin

Net Income

-$11M-27.5% margin

EPS (Diluted)

$-0.09

QoQ Revenue Growth

-27.9%

Cash Flow

Operating Cash Flow

-$125,000

Free Cash Flow

-$976,000

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$483M

Total Liabilities

$103M

Stockholders' Equity

$380M

Cash & Equivalents

$95M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$41M	$45M	-7.6%
Gross Profit	$20M	$23M	-12.4%
Operating Income	-$15M	-$11M	-39.5%
Net Income	-$11M	-$6M	-84.8%

Revenue Segments

Service

$42M60%

Product

$28M40%

Geographic Segments

UNITED STATES

$19M45%

EMEA

$12M28%

Asia Pacific

$9M21%

Other

$2M6%